Why the study?
Low-flow very low-gradient severe AS represents a distinct group with comorbidities and worse outcomes, warranting evaluation of the benefits of TAVR.
Does transcatheter aortic valve replacement improve outcomes in patients with low-flow very low-gradient severe aortic stenosis?
Does transcatheter aortic valve replacement improve outcomes in patients with low-flow very low-gradient severe aortic stenosis?
Answers are grounded in this paper and cite their sources.
Low-flow very low-gradient severe aortic stenosis represents a distinct, high-risk population where the benefits of TAVR require further investigation.
Low-flow very LG severe AS represents a distinct population with significant comorbidities and worse outcomes. Further studies are needed to evaluate the short- and long-term benefits of TAVR in this population.
No takes yet. Share an insight, caveat, or question.
Ueyama et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: